Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arena Pharmaceuticals Inc. (ARNA)

46.67   0.395 (0.85%) 01-17 16:00
Open: 46.69 Pre. Close: 46.275
High: 47.23 Low: 46.3994
Volume: 470,202 Market Cap: 2338M
Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 47.291 - 47.483 47.483 - 47.665
Low: 45.922 - 46.135 46.135 - 46.338
Close: 46.333 - 46.663 46.663 - 46.978

Technical analysis

as of: 2020-01-17 4:34:01 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 56.64     One year: 66.15
Support: Support1: 45.34    Support2: 43.40
Resistance: Resistance1: 48.49    Resistance2: 56.64
Pivot: 45.73
Moving Average: MA(5): 45.77     MA(20): 46.02
MA(100): 47.98     MA(250): 50.51
MACD: MACD(12,26): -0.26     Signal(9): -0.38
Stochastic oscillator: %K(14,3): 60.97     %D(3): 52.50
RSI: RSI(14): 52.77
52-week: High: 64.48  Low: 42.25  Change(%): 6.0
Average Vol(K): 3-Month: 37505  10-Days: 48887

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ARNA has closed below upper band by 3.3%. Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARNA's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-01-16
FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients
SAN DIEGO, Jan. 16, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for APD418, a β3-adrenergic receptor (AdrR) antagonist and cardiac myotrope, in development for the treatment…

2020-01-14
IN BRIEF: Arena Pharmaceuticals swipes top lawyer from DBV Technologies
Arena Pharmaceuticals Inc has tapped Joan Schmidt, a lawyer with decades of in-house experience at biopharmaceutical companies, to replace its general counsel, who is retiring in March.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 50.11
Shares Float (M) 50.02
% Held by Insiders 0.16
% Held by Institutions 85.62
Shares Short (K) 2960
Shares Short P. Month (K)

Stock Financials

EPS 10.840
Book Value (p.s.) 22.930
PEG Ratio -0.28
Profit Margin 68.29
Operating Margin 67.30
Return on Assets (ttm) 36.9
Return on Equity (ttm) 66.1
Qtrly Rev. Growth -62.2
Gross Profit (p.s.) -1.937
Sales Per Share
EBITDA (p.s.) 10.972
Qtrly Earnings Growth
Operating Cash Flow (M) 596.44
Levered Free Cash Flow (M) 386.15

Stock Valuations

P/E 4.31
P/E Growth Ratio 0.01
P/BV 2.04
P/S 2.85
P/CF 3.92

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-06-19
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.